ELI LILLY & Co is 3.6x more valuable than Merck & Co., Inc. by market capitalization ($1.070 T vs $294.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LLY | MRK |
|---|---|---|
| Market cap | $1.070 T | $294.13 B |
| US-listed rank | #10 | #44 |
| Revenue (latest FY) | $65.18B | $65.01B |
| Net income (latest FY) | $20.64B | $18.25B |
| Net margin | 31.7% | 28.1% |
| P/E (trailing FY) | 51.8 | 16.1 |
| SEC filings | 989 | 996 |
ELI LILLY & Co is 3.6x more valuable than Merck & Co., Inc. by market capitalization ($1.070 T vs $294.13 B).
In their latest fiscal years, ELI LILLY & Co reported $65.18B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ELI LILLY & Co and Merck & Co., Inc., or browse the full rankings.